terbutaline has been researched along with dexmedetomidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Batchelor, HN; Bidlack, JM; Brown, E; Dawes, RP; Lordy, KA; Majewska, AK; Sipe, GO; Stoessel, MB; Stowell, RD; Sur, M; Whitelaw, BS | 1 |
1 review(s) available for terbutaline and dexmedetomidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for terbutaline and dexmedetomidine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex.
Topics: Animals; Benzylamines; Cell Movement; Circadian Rhythm; Clenbuterol; CX3C Chemokine Receptor 1; Dexmedetomidine; Dominance, Ocular; Female; Fentanyl; Locus Coeruleus; Male; Mice; Mice, Transgenic; Microglia; Nadolol; Neuronal Plasticity; Neurons; Norepinephrine; Propanolamines; Restraint, Physical; Terbutaline; Visual Cortex; Wakefulness; Wounds and Injuries | 2019 |